Qiagen (QGEN) — insider trading
Health Care · NYSE
Qiagen (QGEN) has 14 reported SEC Form 4 insider transactions in our data, including 10 open-market purchases among the most recent 14 (latest 2017-10-26).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2017-10-26 | QIAGEN NV | 10% owner | Open-market purchase (derivative) | 753,012 | — | $0 | Form 4 |
| 2007-06-15 | QIAGEN NV | 10% owner | Open-market purchase | 10,000 | $1.35 | $13.5K | Form 4 |
| 2007-06-12 | QIAGEN NV | 10% owner | Open-market purchase | 10,000 | $1.29 | $12.9K | Form 4 |
| 2007-06-04 | QIAGEN NV | 10% owner | Open-market purchase | 50,000 | $1.31 | $65.5K | Form 4 |
| 2007-05-31 | QIAGEN NV | 10% owner | Open-market purchase | 5,000 | $1.31 | $6.5K | Form 4 |
| 2007-05-30 | QIAGEN NV | 10% owner | Open-market purchase | 30,000 | $1.31 | $39.3K | Form 4 |
| 2007-05-29 | QIAGEN NV | 10% owner | Open-market purchase | 10,000 | $1.31 | $13.1K | Form 4 |
| 2007-05-23 | QIAGEN NV | 10% owner | Open-market purchase | 17,500 | $1.29 | $22.6K | Form 4 |
| 2007-05-09 | QIAGEN NV | 10% owner | Option exercise (in/at-the-money) (derivative) | 240,000 | — | $0 | Form 4 |
| 2007-05-09 | QIAGEN NV | 10% owner | Option exercise (in/at-the-money) | 240,000 | $0.45 | $108.0K | Form 4 |
| 2007-05-08 | QIAGEN NV | 10% owner | Open-market purchase (derivative) | 240,000 | $0.65 | $156.0K | Form 4 |
| 2007-04-30 | QIAGEN NV | 10% owner | Option exercise (in/at-the-money) (derivative) | 340,000 | — | $0 | Form 4 |
| 2007-04-30 | QIAGEN NV | 10% owner | Open-market purchase (derivative) | 340,000 | $0.65 | $221.0K | Form 4 |
| 2007-04-30 | QIAGEN NV | 10% owner | Option exercise (in/at-the-money) | 340,000 | $0.45 | $153.0K | Form 4 |
Ask the chat about QGEN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Qiagen (QGEN).
Last updated 2017-10-26 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.